Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2131 | ANAB AnaptysBio, Inc. - Common Stock | 57.03 USD | -1.23% | -2.80% | +5.36% | +62.02% | 1.66 B USD | ||
| 2140 | VIR Vir Biotechnology, Inc. - Common Stock | 9.55 USD | -2.35% | +3.24% | +8.28% | +59.70% | 1.62 B USD | ||
| 2143 | ABSI Absci Corporation - Common Stock | 8.96 USD | -6.18% | -1.32% | +15.46% | +243.30% | 1.54 B USD | ||
| 2148 | FBRX Forte Biosciences, Inc. - Common Stock | 76.94 USD | +0.03% | +0.12% | +0.68% | +162.15% | 1.63 B USD | ||
| 2151 | AAPG Ascentage Pharma Group International - American Depository Shar | 16.83 USD | -3.50% | -7.98% | -8.13% | -32.68% | 1.57 B USD | ||
| 2163 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.58 USD | -1.38% | +2.51% | +2.14% | +10.28% | 1.56 B USD | ||
| 2165 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.29 USD | -2.55% | -4.24% | -14.88% | +61.29% | 1.54 B USD | ||
| 2177 | TYRA Tyra Biosciences, Inc. - Common Stock | 25.50 USD | -2.11% | +0.59% | -17.18% | +77.82% | 1.52 B USD | ||
| 2186 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.47 USD | -0.31% | +0.15% | +34.78% | +149.84% | 1.53 B USD | ||
| 2191 | INBX Inhibrx Biosciences, Inc. - Common Stock | 96.27 USD | -7.10% | +8.88% | +16.54% | +19.47% | 1.42 B USD | ||
| 2192 | INVA Innoviva, Inc. - Common Stock | 20.91 USD | -0.76% | -0.85% | -2.74% | +17.34% | 1.51 B USD | ||
| 2204 | NVAX Novavax, Inc. - Common Stock | 8.36 USD | -6.49% | +4.24% | +7.73% | +6.50% | 1.38 B USD | ||
| 2209 | ORIC Oric Pharmaceuticals, Inc. - Common Stock | 13.68 USD | -3.66% | +0.44% | +12.96% | +1.26% | 1.42 B USD | ||
| 2225 | AVBP ArriVent BioPharma, Inc. - Common Stock | 28.77 USD | -1.20% | -1.00% | -9.70% | +39.80% | 1.42 B USD | ||
| 2243 | CGEM Cullinan Therapeutics, Inc. - Common Stock | 21.39 USD | -1.34% | +4.90% | +22.58% | +162.45% | 1.38 B USD | ||
| 2244 | OMER Omeros Corporation - Common Stock | 18.49 USD | -4.05% | +6.76% | +63.63% | +303.71% | 1.34 B USD | ||
| 2245 | REPL Replimune Group, Inc. - Common Stock | 14.25 USD | -3.52% | 0.00% | +63.98% | +152.21% | 1.34 B USD | ||
| 2253 | VOR Vor Biopharma Inc. - Common Stock | 22.14 USD | -5.22% | -1.91% | +14.01% | +69.01% | 1.31 B USD | ||
| 2257 | MGTX MeiraGTx Holdings plc - Ordinary Shares | 13.80 USD | -3.77% | +2.60% | +14.43% | +57.71% | 1.33 B USD | ||
| 2270 | JBIO Jade Biosciences, Inc. - Common Stock | 20.94 USD | -1.87% | -13.86% | +2.35% | +108.36% | 1.33 B USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |